182. Piperacillin/tazobactam (P/T) versus meropenem (Mero) for treatment of extended-spectrum beta-lactamase (ESBL)-producing E.coli and K. pneumoniae bloodstream infections (BSIs)

BACKGROUND: A recent study of Mero vs. P/T for the treatment of BSIs caused by ceftriaxone-resistant Enterobacterales, including ESBL-producing organisms, revealed discouraging outcomes for patients (pts) receiving P/T. The purpose of this study is to evaluate clinical outcomes in pts treated with P...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Alexandra L, Beardsley, James R, Williamson, John C, Stone, Tyler J, DeWitt, Michael E, Palavecino, Elizabeth, Luther, Vera, Taylor, Alex D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677261/
http://dx.doi.org/10.1093/ofid/ofad500.255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677261/
http://dx.doi.org/10.1093/ofid/ofad500.255

Ejemplares similares